Larimar Therapeutics Inc.

NASDAQ: LRMR · Real-Time Price · USD
3.69
-0.21 (-5.38%)
At close: Aug 19, 2025, 1:13 PM

Larimar Therapeutics Revenue

Larimar Therapeutics reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending March 31, 2025, Larimar Therapeutics generated $0 in revenue.
Revenue (ttm)
0
Revenue Growth
n/a
Price / Sales Ratio
0
Revenue / Employee
0
Employees
65
Market Cap
315.4M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 0 n/a
Dec 31, 2023 0 n/a
Dec 31, 2022 0 n/a
Dec 31, 2021 0 n/a
Dec 31, 2020 0 n/a
Dec 31, 2019 0 n/a
Dec 31, 2018 0 n/a
Dec 31, 2017 0 n/a
Dec 31, 2016 0 n/a
Dec 31, 2015 0 n/a
Dec 31, 2014 0 n/a
Dec 31, 2013 0 n/a
Dec 31, 2012 0 n/a
Dec 31, 2011 0 n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.